Unibest 优贝德
← Back to patent-cliff list

CAS 81058-27-7

(2R,3R,4S,5R,6R)-2-bromo-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-3,4,5-triyl tris(2,2-dimethylpropanoate)

Codes:DAPA-015、CANA-018

Application context (from source-drug indications)

二型糖尿病达格列净丙二醇/盐酸二甲双胍终末期肾脏病卡格列净/盐酸二甲双胍心脏和血管疾病卡格列净/盐酸二甲双胍腹主动脉瘤卡格列净/盐酸二甲双胍二型糖尿病卡格列净/盐酸二甲双胍

Source drugs (routes using this intermediate)

DrugTierExpiry
达格列净丙二醇/盐酸二甲双胍Dapagliflozin Propanediol/Metformin HydrochlorideTier A — Act now2030
卡格列净/盐酸二甲双胍Canagliflozin/Metformin HydrochlorideTier B — Position early2029

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.